The role of natural killer cells in autoimmune diseases

UC Kucuksezer, E Aktas Cetin, F Esen… - Frontiers in …, 2021 - frontiersin.org
Natural killer (NK) cells, the large granular lymphocytes differentiated from the common
lymphoid progenitors, were discovered in early 1970's. They are members of innate …

Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations

S Kalra, A Silman, G Akman-Demir, S Bohlega… - Journal of …, 2014 - Springer
Neuro-Behçet's disease (NBD) is one of the more serious manifestations of Behçet's disease
(BD), which is a relapsing inflammatory multisystem disease with an interesting …

Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism

S Lindström, LU Wang, EN Smith… - Blood, The Journal …, 2019 - ashpublications.org
Venous thromboembolism (VTE) is a significant contributor to morbidity and mortality. To
advance our understanding of the biology contributing to VTE, we conducted a genome …

Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1

Y Kirino, G Bertsias, Y Ishigatsubo, N Mizuki… - Nature …, 2013 - nature.com
Individuals with Behçet's disease suffer from episodic inflammation often affecting the
orogenital mucosa, skin and eyes. To discover new susceptibility loci for Behçet's disease …

Neuro-Behçet's disease: epidemiology, clinical characteristics, and management

A Al-Araji, DP Kidd - The Lancet Neurology, 2009 - thelancet.com
Behçet's disease (BD) is a multisystem relapsing inflammatory disorder of unknown cause.
In neuro-BD (NBD), the CNS can be involved in one or both of two ways: first, and most …

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients

A Arida, K Fragiadaki, E Giavri, PP Sfikakis - Seminars in arthritis and …, 2011 - Elsevier
OBJECTIVE:: Off-label use of anti-tumor necrosis factor (TNF) agents for Behçet's disease
(BD) is increasing. We evaluated published data on their efficacy and safety for patients with …

Epidemiology and clinical characteristics of Behçet's disease in the US: a population‐based study

KT Calamia, FC Wilson, M Icen… - Arthritis Care & …, 2009 - Wiley Online Library
Objective Behçet's disease (BD) is a rare, multisystem inflammatory disorder of unknown
cause. Although well‐documented in Eastern populations, epidemiologic data is scarce in …

A cutoff value for the Systemic Immune‐Inflammation Index in determining activity of Behçet disease

E Tanacan, D Dinçer, FG Erdogan… - Clinical and …, 2021 - academic.oup.com
Background Behçet disease (BD) is an immune‐mediated vasculitis‐like syndrome
characterized by recurrent aphthous lesions and various systemic manifestations …

[HTML][HTML] Autoimmune diseases and venous thromboembolism: a review of the literature

B Zöller, X Li, J Sundquist… - American journal of …, 2012 - ncbi.nlm.nih.gov
Venous thromboembolism (VTE) is major health problem and is sometimes complicated by
lethal pulmonary embolism (PE). Disturbances of the coagulation and anticoagulation …

Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes

M Kaustio, E Haapaniemi, H Göös, T Hautala… - Journal of Allergy and …, 2017 - Elsevier
Background The nuclear factor κ light-chain enhancer of activated B cells (NF-κB) signaling
pathway is a key regulator of immune responses. Accordingly, mutations in several NF-κB …